Ribavirin Powder, For Solution
Product Images NDC 68382-395

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ribavirin (NDC 68382-395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2fa973e9 7fdb 48ff A2dc D8d4dcffc226 01

FDA Label Image

2fa973e9 7fdb 48ff A2dc D8d4dcffc226 02

2fa973e9 7fdb 48ff A2dc D8d4dcffc226 02
This is a medication package insert for a drug that may be administered through inhalation, containing information on dosage and administration, along with storage conditions and manufacturer details. The drug can be reconstituted with sterile water and may contain ribavirin. The drug should be stored between 15 to 30°C (59° to 86°F) and is only meant for aerosol inhalation. The medication is distributed by Zydus Pharmaceuticals USA Inc. with a lot number and expiration date provided.*
FDA Label Image

2fa973e9 7fdb 48ff A2dc D8d4dcffc226 03

2fa973e9 7fdb 48ff A2dc D8d4dcffc226 03
Ribavirin for inhalation solution, USP is a sterile lyophilized medication that comes in a package of four 6-gram vials for administration by aerosol inhalation only. The packaging indicates there is a "no coating area", which means that the medication is not coated with any additional substances.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.